Expert recommendations on supportive skin care for non-surgical and surgical procedures.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
09
09
2022
accepted:
04
01
2023
pubmed:
13
1
2023
medline:
14
2
2023
entrez:
12
1
2023
Statut:
ppublish
Résumé
A thorough knowledge of non-surgical procedures (laser, peelings, injections, threads) and surgical procedures (combined surgeries and skin grafts), including contraindications and potential risks and side effects, (e.g. infection, hypopigmentation, hyperpigmentation, and scarring) is essential to be able to reduce their incidence and ensure the patient receives the most benefit from the procedure. Individuals with darker skin and of high Fitzpatrick phototype are at higher risk of dyschromias, notably melasma and post-inflammatory hyperpigmentation, which may be treated using aesthetic procedures but may also arise as a complication of some procedures. A group of experts in cosmetic surgery and dermatology reviewed the published literature and discussed recommendations for optimizing outcomes with practical advice on supportive skincare before, during and after non-surgical or surgical procedures. A broad-spectrum sunscreen with a high sun protection factor against UVB and high protection against UVA, especially long UVA, is essential for all treatment modalities for the prevention and potential improvement of pigmentation disorders. Supportive skin care management to prepare, cleanse and protect the skin and post-procedure skin care with healing and anti-inflammatory ingredients are recommended to speed up regeneration and wound healing whilst minimizing scarring and downtime. Additionally, adjunctive skin care to procedures with antioxidant, anti-ageing and lightening properties may enhance skin benefits.
Substances chimiques
Sunscreening Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
16-33Subventions
Organisme : La Roche-Posay
Informations de copyright
© 2023 European Academy of Dermatology and Venereology.
Références
Kouris A, Platsidaki E, Christodoulou C, Efstathiou V, Markantoni V, Armyra K, et al. Patients' self-esteem before and after chemical peeling procedure. J Cosmet Laser Ther. 2018;20(4):220-2.
Sherber N. The millennial mindset. J Drugs Dermatol. 2018;17(12):1340-2.
Wang JV, Rieder EA, Schoenberg E, Zachary CB, Saedi N. Patient perception of beauty on social media: professional and bioethical obligations in esthetics. J Cosmet Dermatol. 2020;19(5):1129-30.
Di Gesto C, Nerini A, Policardo GR, Matera C. Predictors of acceptance of cosmetic surgery: instagram images-based activities, appearance comparison and body dissatisfaction among women. Aesthetic Plast Surg. 2022;46(1):502-12.
Hamilton MM, Kao R. Recognizing and managing complications in laser resurfacing, chemical peels, and dermabrasion. Facial Plast Surg Clin North Am. 2020;28(4):493-501.
Amici JM, Chaussade V. [How to optimize scarring in dermatologic surgery?]. Ann Dermatol Venereol. 2016;143(Suppl 2):S20-s5.
Jourdan M, Madfes DC, Lima E, Tian Y, Seité S. Skin care management for medical and aesthetic procedures to prevent scarring. Clin Cosmet Investig Dermatol. 2019;12:799-804.
Cestari TF, Dantas LP, Boza JC. Acquired hyperpigmentations. An Bras Dermatol. 2014;89(1):11-25.
Sofen B, Prado G, Emer J. Melasma and post inflammatory hyperpigmentation: management update and expert opinion. Skin Therapy Lett. 2016;21(1):1-7.
Passeron T, Lim HW, Goh CL, Kang HY, Ly F, Morita A, et al. Photoprotection according to skin phototype and dermatoses: practical recommendations from an expert panel. J Eur Acad Dermatol Venereol. 2021;35(7):1460-9.
Del Bino S, Duval C, Bernerd F. Clinical and biological characterization of skin pigmentation diversity and its consequences on UV impact. Int J Mol Sci. 2018;19(9):2668.
Araviiskaia E, Le Pillouer PA, Kosmadaki M, Kerob D, Roo E. Recommendations for the use of corrective makeup after dermatological procedures. J Cosmet Dermatol. 2022;21(4):1554-8.
Bolognia J, Jorizzo JL, Schaffer JV. Dermatology. Philadelphia, PA: Elsevier Saunders; 2012.
Alster T, Hirsch R. Single-pass CO2 laser skin resurfacing of light and dark skin: extended experience with 52 patients. J Cosmet Laser Ther. 2003;5(1):39-42.
Angra K, Lipp MB, Sekhon S, Wu DC, Goldman MP. Review of post-laser-resurfacing topical agents for improved healing and cosmesis. J Clin Aesthet Dermatol. 2021;14(8):24-32.
Waibel JS, Mi QS, Ozog D, Qu L, Zhou L, Rudnick A, et al. Laser-assisted delivery of vitamin C, vitamin E, and ferulic acid formula serum decreases fractional laser postoperative recovery by increased beta fibroblast growth factor expression. Lasers Surg Med. 2016;48(3):238-44.
Li W, Yu Q, Shen Z, Zhang Z, Li C, Li C, et al. Effects of a cream containing madecassoside, 5% panthenol, and copper-zinc-manganese on improving postlaser resurfacing wound healing: a split-face, randomized trial. Dermatol Ther. 2020;33(4):e13533.
Lueangarun S, Srituravanit A, Tempark T. Efficacy and safety of moisturizer containing 5% panthenol, madecassoside, and copper-zinc-manganese versus 0.02% triamcinolone acetonide cream in decreasing adverse reaction and downtime after ablative fractional carbon dioxide laser resurfacing: a split-face, double-blinded, randomized, controlled trial. J Cosmet Dermatol. 2019;18(6):1751-7.
Heise R, Schmitt L, Huth L, Krings L, Kluwig D, Katsoulari KV, et al. Accelerated wound healing with a dexpanthenol-containing ointment after fractional ablative CO(2) laser resurfacing of photo-damaged skin in a randomized prospective clinical trial. Cutan Ocul Toxicol. 2019;38(3):274-8.
Gorski J, Proksch E, Baron JM, Schmid D, Zhang L. Dexpanthenol in wound healing after medical and cosmetic interventions (postprocedure wound healing). Pharmaceuticals (Basel). 2020;13(7):138.
Passeron T, Fontas E, Kang HY, Bahadoran P, Lacour JP, Ortonne JP. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. Arch Dermatol. 2011;147(9):1106-8.
Lueangarun S, Namboonlue C, Tempark T. Postinflammatory and rebound hyperpigmentation as a complication after treatment efficacy of telangiectatic melasma with 585 nanometers Q-switched Nd: YAG laser and 4% hydroquinone cream in skin phototypes III-V. J Cosmet Dermatol. 2021;20(6):1700-8.
Sardana K, Chugh S, Garg VK. Which therapy works for melasma in pigmented skin: lasers, peels, or triple combination creams? Indian J Dermatol Venereol Leprol. 2013;79(3):420-2.
Seité S, Bensadoun RJ, Mazer JM. Prevention and treatment of acute and chronic radiodermatitis. Breast Cancer (Dove Med Press). 2017;9:551-7.
Grevelink JM, Duke D, van Leeuwen RL, Gonzalez E, DeCoste SD, Anderson RR. Laser treatment of tattoos in darkly pigmented patients: efficacy and side effects. J Am Acad Dermatol. 1996;34(4):653-6.
Jones A, Roddey P, Orengo I, Rosen T. The Q-switched ND:YAG laser effectively treats tattoos in darkly pigmented skin. Dermatol Surg. 1996;22(12):999-1001.
Meesters AA, De Rie MA, Wolkerstorfer A. Generalized eczematous reaction after fractional carbon dioxide laser therapy for tattoo allergy. J Cosmet Laser Ther. 2016;18(8):456-8.
van der Bent SAS, Huisman S, Rustemeyer T, Wolkerstorfer A. Ablative laser surgery for allergic tattoo reactions: a retrospective study. Lasers Med Sci. 2021;36(6):1241-8.
Nisticò SP, Cannarozzo G, Provenzano E, Tamburi F, Fazia G, Sannino M, et al. Nanosecond Q-switched 1064/532 nm laser to treat hyperpigmentations: a double center retrospective study. Clin Pract. 2021;11(4):708-14.
Puaratanaarunkon T, Asawanonda P. A randomized, double blinded, split-face study of the efficacy of using a broad spectrum sunscreen with anti-inflammatory agent to reduce post inflammatory hyperpigmentation after picosecond laser. Clin Cosmet Investig Dermatol. 2022;15:331-7.
Molinar VE, Taylor SC, Pandya AG. What's new in objective assessment and treatment of facial hyperpigmentation? Dermatol Clin. 2014;32(2):123-35.
Ko D, Wang RF, Ozog D, Lim HW, Mohammad TF. Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation. J Am Acad Dermatol. 2023;88(2):291-320.
Hu S, Atmakuri M, Rosenberg J. Adverse events of nonablative lasers and energy-based therapies in subjects with Fitzpatrick skin Phototypes IV to VI: a systematic review and meta-analysis. Aesthet Surg J. 2022;42(5):537-47.
Loh TY, Goldberg MS, Falsey RR, Barton JK, Sagerman P, Goldberg GN. Insight into the mechanisms of type III minocycline-induced pigmentation removal: a case of repeated immediate pigment clearing with the Q-switched 755-nm alexandrite laser over a 13-year period. JAAD Case Rep. 2019;5(10):865-7.
Carrancho Garcia A, Garrote Llordén A, Cordero CM. Ocular complications secondary to diode laser-assisted eyebrow epilation. Arch Soc Esp Oftalmol (Engl Ed). 2022;97(3):172-5.
Kelati A, Lagrange S, Le Duff F, et al. Laser hair removal after surgery vs. surgery alone for the treatment of pilonidal cysts: a retrospective case-control study. J Eur Acad Dermatol Venereol. 2018;32(11):2031-3.
Liyanage A, Woods Y, Javed MA, Deftly C, Shaban H, Kalaiselvan R, et al. Laser depilation as adjuvant therapy in prevention of recurrence of pilonidal sinus disease: initial experience of a district general hospital in the UK. Ann R Coll Surg Engl. 2020;102(9):685-8.
Arsiwala SZ, Majid IM. Methods to overcome poor responses and challenges of laser hair removal in dark skin. Indian J Dermatol Venereol Leprol. 2019;85(1):3-9.
Aldraibi MS, Touma DJ, Khachemoune A. Hair removal with the 3-msec alexandrite laser in patients with skin types IV-VI: efficacy, safety, and the role of topical corticosteroids in preventing side effects. J Drugs Dermatol. 2007;6(1):60-6.
Rao K, Sankar TK. Long-pulsed Nd:YAG laser-assisted hair removal in Fitzpatrick skin types IV-VI. Lasers Med Sci. 2011;26(5):623-6.
Bs B, Chittoria RK, Thappa DM, et al. Are lasers superior to lights in the photoepilation of Fitzpatrick V and VI skin types? - a comparison between Nd:YAG laser and intense pulsed light. J Cosmet Laser Ther. 2017;19(5):252-5.
Fayne RA, Perper M, Eber AE, Aldahan AS, Nouri K. Laser and light treatments for hair reduction in Fitzpatrick skin types IV-VI: a comprehensive review of the literature. Am J Clin Dermatol. 2018;19(2):237-52.
Moftah N, Tymour M, Ibrahim SMA. Multipass low fluence, high-frequency 755-nm alexandrite laser versus high fluence, low-frequency 1064-nm long-pulsed Nd: YAG laser in axillary hair reduction of dark skin phototypes: an intra-individual randomized comparative study. J Dermatolog Treat. 2022;1-6:2079-84.
Dorgham NA, Dorgham DA. Lasers for reduction of unwanted hair in skin of colour: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2020;34(5):948-55.
Zeitouni NC, Bhatia N, Ceilley RI, Cohen JL, del Rosso J, Moore AY, et al. Photodynamic therapy with 5-aminolevulinic acid 10% gel and red light for the treatment of actinic keratosis, nonmelanoma skin cancers, and acne: current evidence and best practices. J Clin Aesthet Dermatol. 2021;14(10):E53-e65.
Morton CA, Szeimies RM, Braathen LR. Review of the European Society for Photodynamic Therapy (euro-PDT) annual congress 2020. Eur J Dermatol. 2021;31(1):17-21.
Harries MJ, Street G, Gilmour E, Rhodes LE, Beck MH. Allergic contact dermatitis to methyl aminolevulinate (Metvix) cream used in photodynamic therapy. Photodermatol Photoimmunol Photomed. 2007;23(1):35-6.
Wenande E, Phothong W, Bay C, Karmisholt KE, Haedersdal M, Togsverd-Bo K. Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side-by-side, single-blind trial in patients with actinic keratosis and large-area field cancerization. Br J Dermatol. 2019;180(4):756-64.
Lonsdorf AS, Keller A, Hartmann J, Enk AH, Gholam P. Ablative fractional laser-assisted low-irradiance photodynamic therapy is more effective than conventional methylaminolaevulinate - photodynamic therapy for the treatment of actinic keratoses in organ transplant recipients: a prospective randomized intra-individual controlled trial. Acta Derm Venereol. 2022;102:adv00694.
Togsverd-Bo K, Lei U, Erlendsson AM, Taudorf EH, Philipsen PA, Wulf HC, et al. Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - a randomized controlled trial. Br J Dermatol. 2015;172(2):467-74.
Seo JW, Song KH. Topical calcipotriol before ablative fractional laser-assisted photodynamic therapy enhances treatment outcomes for actinic keratosis in Fitzpatrick grades III-V skin: a prospective randomized clinical trial. J Am Acad Dermatol. 2018;78(4):795-7.
Landau M. Chemical peels. Clin Dermatol. 2008;26(2):200-8.
Castillo DE, Keri JE. Chemical peels in the treatment of acne: patient selection and perspectives. Clin Cosmet Investig Dermatol. 2018;11:365-72.
Ali B, ElMahdy N, Elfar NN. Microneedling (Dermapen) and Jessner's solution peeling in treatment of atrophic acne scars: a comparative randomized clinical study. J Cosmet Laser Ther. 2019;21(6):357-63.
Del Rosario E, Florez-Pollack S, Zapata L Jr, et al. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma. J Am Acad Dermatol. 2018;78(2):363-9.
Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg. 1999;25(1):18-22.
Burns RL, Prevost-Blank PL, Lawry MA, Lawry TB, Faria DT, Fivenson DP. Glycolic acid peels for postinflammatory hyperpigmentation in black patients. A comparative study. Dermatol Surg. 1997;23(3):171-4; discussion 5.
Vemula S, Maymone MBC, Secemsky EA, Widjajahakim R, Patzelt NM, Saade D, et al. Assessing the safety of superficial chemical peels in darker skin: a retrospective study. J Am Acad Dermatol. 2018;79(3):508-13.e2.
Dayal S, Kalra KD, Sahu P. Comparative study of efficacy and safety of 45% mandelic acid versus 30% salicylic acid peels in mild-to-moderate acne vulgaris. J Cosmet Dermatol. 2020;19(2):393-9.
Dayal S, Singh S, Sahu P. Efficacy and safety of 25% Trichloroacetic acid Peel versus 30% salicylic acid Peel in mild-to-moderate acne vulgaris: a comparative study. Dermatol Pract Concept. 2021;11(3):e2021063.
Lee KC, Wambier CG, Soon SL, Sterling JB, Landau M, Rullan P, et al. Basic chemical peeling: superficial and medium-depth peels. J Am Acad Dermatol. 2019;81(2):313-24.
Hausauer AK, Humphrey S. The physician's guide to platelet-rich plasma in dermatologic surgery part II: clinical evidence. Dermatol Surg. 2020;46(4):447-56.
Black JM. Commentary on The physician's guide to platelet-rich plasma in dermatologic surgery part I and The physician's guide to platelet-rich plasma in dermatologic surgery part II. Dermatol Surg. 2020;46(4):457-8.
Kang C, Lu D. Combined effect of microneedling and platelet-rich plasma for the treatment of acne scars: a meta-analysis. Front Med. 2022;8:788754.
Nagamoto H, Yamamoto N, Itoi E. Effect of anchor threads on the pullout strength: a biomechanical study. J Orthop. 2018;15(3):878-81.
Palm MD, Few J, Patel T, Safa M, Drinkwater A, Mao C, et al. Efficacy, patient-reported outcomes, and safety for millennial subjects treated with OnabotulinumtoxinA for moderate to severe horizontal forehead lines. Dermatol Surg. 2020;46(5):653-61.
Schlessinger J, Gilbert E, Cohen JL, Kaufman J. New uses of AbobotulinumtoxinA in aesthetics. Aesthet Surg J. 2017;37(suppl_1):S45-s58.
Beleznay K, Carruthers JD, Humphrey S, Jones D. Avoiding and treating blindness from fillers: a review of the world literature. Dermatol Surg. 2015;41(10):1097-117.
Scheuer JF 3rd, Sieber DA, Pezeshk RA, Gassman AA, Campbell CF, Rohrich RJ. Facial danger zones: techniques to maximize safety during soft-tissue filler injections. Plast Reconstr Surg. 2017;139(5):1103-8.
Beeson W, Tang J, Croix J, Sattler G, Hanke C. Anatomical considerations for injectable fillers in the face: how to reduce complications and optimize aesthetic results. J Drugs Dermatol. 2022;21(4):354-62.
DeLorenzi C. New high dose pulsed hyaluronidase protocol for hyaluronic acid filler vascular adverse events. Aesthet Surg J. 2017;37(7):814-25.
Murray G, Convery C, Walker L, Davies E. Guideline for the safe use of hyaluronidase in aesthetic medicine, including modified high-dose protocol. J Clin Aesthet Dermatol. 2021;14(8):E69-75.
Broly M, Marie J, Picard C, Demoures A, Raimbault C, Beylot-Barry M, et al. Management of granulomatous foreign body reaction to fillers with methotrexate. J Eur Acad Dermatol Venereol. 2020;34(4):817-20.
Seite S. Thermal waters as cosmeceuticals: La Roche-Posay thermal spring water example. Clin Cosmet Investig Dermatol. 2013;6:23-8.
Seité S, Deshayes P, Dréno B, et al. Interest of corrective makeup in the management of patients in dermatology. Clin Cosmet Investig Dermatol. 2012;5:123-8.
Amici JM, Taïeb C, LeFloc'h C, Demessant-Flavigny AL, Seité S, Cogrel O. Prevalence of scars: an international epidemiological survey in adults. J Eur Acad Dermatol Venereol. 2022;36:e799-800.
Tziotzios C, Profyris C, Sterling J. Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics part II. Strategies to reduce scar formation after dermatologic procedures. J Am Acad Dermatol. 2012;66(1):13-24; quiz 5-6.
Kerwin LY, El Tal AK, Stiff MA, Fakhouri TM. Scar prevention and remodeling: a review of the medical, surgical, topical and light treatment approaches. Int J Dermatol. 2014;53(8):922-36.
Ogawa R. The Most current algorithms for the treatment and prevention of hypertrophic scars and keloids: a 2020 update of the algorithms published 10 years ago. Plast Reconstr Surg. 2022;149(1):79 e-94 e.
Sclafani AP, Sclafani JA, Sclafani AM. Successes, revisions, and postoperative complications in 446 Mohs defect repairs. Facial Plast Surg. 2012;28(3):358-66.
Amici JM, Bailly JY, Taieb A. Horizontal stretching concept in oncologic dermatologic surgery of the face. J Eur Acad Dermatol Venereol. 2010;24(3):308-16.
Monstrey S, Middelkoop E, Vranckx JJ, Bassetto F, Ziegler UE, Meaume S, et al. Updated scar management practical guidelines: non-invasive and invasive measures. J Plast Reconstr Aesthet Surg. 2014;67(8):1017-25.
Rosengren H, Askew DA, Heal C, Buettner PG, Humphreys WO, Semmens LA. Does taping torso scars following dermatologic surgery improve scar appearance? Dermatol Pract Concept. 2013;3(2):75-83.
Wong VW, Levi K, Akaishi S, Schultz G, Dauskardt RH. Scar zones: region-specific differences in skin tension may determine incisional scar formation. Plast Reconstr Surg. 2012;129(6):1272-6.
Amici JM. [Early hypertrophic scar after surgery on the nasal region: value of long-acting corticosteroid injections]. Ann Dermatol Venereol. 2014;141(1):7-13.
Shin TM, Bordeaux JS. The role of massage in scar management: a literature review. Dermatol Surg. 2012;38(3):414-23.
McGoldrick RB, Theodorakopoulou E, Azzopardi EA, Murison M. Lasers and ancillary treatments for scar management part 2: keloid, hypertrophic, pigmented and acne scars. Scars Burn Heal. 2017;3:2059513116689805.
Ruchiatan K, Suhada KU, Hindritiani R, Puspitosari D, Septrina R. Combination of 1064 nm long-pulsed and Q-switched Nd:YAG laser for facial hypertrophic scar and hyperpigmentation following burn injury. Int Med Case Rep J. 2022;15:23-7.
Massaki AB, Fabi SG, Fitzpatrick R. Repigmentation of hypopigmented scars using an erbium-doped 1,550-nm fractionated laser and topical bimatoprost. Dermatol Surg. 2012;38(7 Pt 1):995-1001.
Jadhav SB, Shah N, Rathi A, Rathi V, Rathi A. Serratiopeptidase: insights into the therapeutic applications. Biotechnol Rep (Amst). 2020;28:e00544.